Advertisement
Singapore markets close in 5 hours 18 minutes
  • Straits Times Index

    3,276.24
    -11.51 (-0.35%)
     
  • Nikkei

    37,780.35
    +151.87 (+0.40%)
     
  • Hang Seng

    17,610.66
    +326.12 (+1.89%)
     
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • Bitcoin USD

    64,373.09
    -25.31 (-0.04%)
     
  • CMC Crypto 200

    1,391.38
    +8.81 (+0.64%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,345.10
    +2.60 (+0.11%)
     
  • Crude Oil

    83.81
    +0.24 (+0.29%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,572.11
    +2.86 (+0.18%)
     
  • Jakarta Composite Index

    7,113.27
    -42.02 (-0.59%)
     
  • PSE Index

    6,556.96
    -17.92 (-0.27%)
     

Company News For Aug 21, 2018

IDACORP has been struggling lately, but the selling pressure may be coming to an end soon.
  • The Estée Lauder Companies Inc. EL shares surged 3.4% after the company reported fiscal fourth-quarter 2018 adjusted earnings per share of $0.61 surpassing the Zacks Consensus Estimate of $0.56

  • ConocoPhillips COP increased 1.1% following its $2 billion settlement with Venezuelan state-owned oil giant PDVSA as pera International Chamber of Commerce directive

  • Praxair Inc.’s PX shares rose 1.4% following the news that it received EU’s regulatory nod related to its merger with German industrial gases group Linde

  • Shares of Amneal Pharmaceuticals Inc. AMRX jumped 12.8% after a 10-year license and supply contract for levothyroxine sodium tablets was signed between the company and  Jerome Stevens Pharmaceuticals


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Praxair, Inc. (PX) : Free Stock Analysis Report
 
The Estee Lauder Companies Inc. (EL) : Free Stock Analysis Report
 
ConocoPhillips (COP) : Free Stock Analysis Report
 
Impax Laboratories, Inc. (AMRX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research